Lead Optimization of Novel Site-Selective Blockers of Mitochondrial Complex III ROS as FTD Therapeutics

Project Number
ADDF-4
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Year
2020
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Anna
Principal Investigator Last Name
Orr
Awardee Organization
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$135,000
Funding Organization
Agency/Funding Organization
Funding Organization Country